Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer - Samuel A. Jacobs; Ying Wang; Jame Abraham; Huichen Feng; Alberto J. Montero; Corey Lipchik; Melanie Finnigan; Rachel C. Jankowitz; Mohamad A. Salkeni; Sai K. Maley; Shannon L. Puhalla; Fanny Piette; et al. (Breast Cancer Research, 2024)